Bortezomib potentiates antitumor activity of mitoxantrone through dampening Wnt/β-catenin signal pathway in prostate cancer cellsYing Zhang(Jining Medical University), Changlin Li(Jining Medical University)BMC CancerOctober 13, 202110.1186/s12885-021-08841-1Cited by 9SaveCiteExport RISWatch citationsRelated PapersMitoxantrone triggers immunogenic prostate cancer cell death via p53-dependent PERK expression|Cellular Oncology|2020|63Transcriptome and Proteome Analysis Reveals Corosolic Acid Inhibiting Bladder Cancer via Targeting Cell Cycle and Inducing Mitophagy in Vitro and in Vivo|Research Square|2021|3